Fitch Affirms BBB+ Rating on Agilent's $2.8B of Debt | GenomeWeb

NEW YORK (GenomeWeb News) – Fitch Ratings today affirmed BBB+ ratings for about $2.8 billion of Agilent Technologies' debt, noting the firm's ongoing revenue diversification and conservative financial policies.

Fitch issued BBB+ ratings on Agilent's issuer default rating, senior unsecured revolving credit facility, and senior unsecured notes. The ratings affect about $2.8 billion of debt, including an undrawn $400 million revolving credit facility that expires in 2016, the ratings firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.